RT Journal Article
SR Electronic
T1 SARS-CoV-2 infects, replicates, elevates angiotensin II and activates immune cells in human testes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.05.22270327
DO 10.1101/2022.02.05.22270327
A1 Costa, Guilherme M.J.
A1 Lacerda, Samyra M.S.N.
A1 Figueiredo, André F.A.
A1 Wnuk, Natália T.
A1 Brener, Marcos R. G.
A1 Campolina-Silva, Gabriel H.
A1 Kauffmann-Zeh, Andrea
A1 Pacifico, Lucila GG
A1 Versiani, Alice F.
A1 Andrade, Lídia M.
A1 Antunes, Maísa M.
A1 Souza, Fernanda R.
A1 Cassali, Geovanni D.
A1 Caldeira-Brant, André L.
A1 Chiarini-Garcia, Hélio
A1 Costa, Vivian V.
A1 da Fonseca, Flavio G.
A1 Nogueira, Maurício L.
A1 Campos, Guilherme R. F.
A1 Kangussu, Lucas M.
A1 Martins, Estefânia M. N.
A1 Antonio, Loudiana M.
A1 Bittar, Cintia
A1 Rahal, Paula
A1 Aguiar, Renato S.
A1 Mendes, Bárbara P.
A1 Procópio, Marcela S.
A1 Furtado, Thiago P.
A1 Guimaraes, Yuri L
A1 Menezes, Gustavo B
A1 Martinez-Marchal, Ana
A1 Brieno-Enriquez, Miguel
A1 Orwig, Kyle E.
A1 Furtado, Marcelo H.
YR 2022
UL http://medrxiv.org/content/early/2022/02/08/2022.02.05.22270327.abstract
AB Although much has been published since the first cases of COVID-19, there remain unanswered questions regarding SARS-CoV-2 impact on testes and the potential consequences for reproductive health. We investigated testicular alterations in deceased COVID-19-patients, the precise location of the virus, its replicative activity, and the molecules involved in the pathogenesis. We found that SARS-CoV-2 testicular tropism is higher than previously thought and that reliable viral detection in the testis requires sensitive nanosensoring or RT-qPCR using a specific methodology. Macrophages and spermatogonial cells are the main SARS-CoV-2 lodging sites and where new virions form inside the Endoplasmic Reticulum Golgi Intermediate Complex. Moreover, we showed infiltrative infected monocytes migrating into the testicular parenchyma. SARS-CoV-2 maintains its replicative and infective abilities long after the patient’s infection, suggesting that the testes may serve as a viral sanctuary. Further, infected testes show thickening of the tunica propria, germ cell apoptosis, Sertoli cell barrier loss, evident hemorrhage, angiogenesis, Leydig cell inhibition, inflammation, and fibrosis. Finally, our findings indicate that high angiotensin II levels and activation of mast cells and macrophages may be critical for testicular pathogenesis. Importantly, our data suggest that patients who become critically ill exhibit severe damages and may harbor the active virus in testes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was primarily financed by Ferring COVID19 Investigational Grant (grant FIN0042393, to G.M.J.C). G.M.J.C. also received resources from FAPEMIG (APQ0107821). Other specific grants from coauthors punctually helped in some experiments and logistics of the present study. A.F.V. was supported by a FAPESP (grant #18/176470) when the study was conducted. G.R.F.C. is supported by a FAPESP (grant #20/074190). M.H.F. was supported by the Laboratorio Sao Paulo/BH/MG. M.L.N. is supported by FAPESP (grant # 2019/072509 and #2020/048360) and CNPq. F.G.F. received grants from FAPEMIG (CBBAPQ0308117, and CBBAPQ0429517), and from Rede Mineira de Pesquisa e Inovacao para Bioengenharia de Nanossistemas (RM PIBEM FAPEMIG TEC RED0028216). R.S.A was supported by CNPq (R.S.A.: 312688/20172 and 439119/20189).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Research Ethics Committee of the Mater Dei Hospital and the National Research Ethics Committee (CONEP) approved this investigation under the number CAAE: 30999320.1.0000.5128. Testicular fragments were obtained after the study was approved by the Ethics Committee in Research of the Universidade Federal de Minas Gerais COEP/UFMG (COEP ETIC 104 n117/07)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors